Companies: 10,795·Total market cap: $144.5T
SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

SWTXNASDAQHealthcare
$46.99
+$0.01(+0.02%)
Market Cap$3.5B
P/E Ratio
52W High$62
52W Low$28.21
Overview

SpringWorks Therapeutics, Inc. (SWTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SWTX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.41swtx eps ttm · swtx earnings per shareEarnings history
PE Ratio (TTM)swtx pe ratio ttm · swtx price to earningsPE Ratio deep dive
Revenue (TTM)$219.7Mswtx revenue ttm · swtx annual revenueFull revenue history
Dividend YieldNo Dividenddoes swtx pay dividends · swtx dividend yieldDividend history
Shares Outstanding74.1Mswtx shares outstanding · swtx floatShares outstanding history
Next EarningsTBAswtx earnings date · swtx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$191.6M▲ +3417.33% YoY
202220232024
springworks therapeutics, inc. revenue · swtx revenue 2024
FY 2024Net Income-$258.1M▲ +20.60% YoY
202220232024
springworks therapeutics, inc. net income · swtx profit 2024
FY 2024EPS$-3.48▲ +32.43% YoY
202220232024
swtx eps · springworks therapeutics, inc. earnings per share 2024
TTM:Revenue: $219.7MNet Income: -$253.9MEPS: $-3.41View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis swtx a buy · swtx analyst rating
Strong Buy
0
Buy
7
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$47.00Low
$46.99Current
$65.40Avg Target39.18% upside
$78.00High
swtx price target · swtx 12 month forecast

Total: 11 · Buy rate: 63.6%

The SWTX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $65.40, representing +39.18% upside from the current price of $46.99.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+1.49%
YTD+30.24%
1Y+30.85%
5Y+10.23%

About SpringWorks Therapeutics, Inc.

CEOSaqib Islam
IPO DateSep 13, 2019
Employees368
CountryUS

SpringWorks Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies for patient populations grappling with rare diseases and va…

what is springworks therapeutics, inc. · swtx stock overview · springworks therapeutics, inc. company profile · who is springworks therapeutics, inc. ceo · swtx NASDAQ · springworks therapeutics, inc. headquarters · springworks therapeutics, inc. business segments

About Stock Overview & Key Data

SpringWorks Therapeutics, Inc. (SWTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 13, 2019. As of the latest trading session, SWTX stock price is $46.99, with a market capitalization of $3.5B. The stock has returned +30.85% over the past 12 months and +30.24% year-to-date.

According to 11 Wall Street analysts, the consensus rating for SpringWorks Therapeutics, Inc. stock is Buy, with an average 12-month price target of $65.40. In fiscal year 2024, SpringWorks Therapeutics, Inc. reported revenue of $191.6M and net income of -$258.1M. For detailed data — including SpringWorks Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, SpringWorks Therapeutics, Inc. (SWTX) stock price is $46.99. The stock is traded on NASDAQ under the ticker symbol SWTX. The 52-week range is $28.21 – $62.00.

SWTX stock priceSWTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice